NCT03329729View on ClinicalTrials.gov

PLATOREL® STUDY IN CARDIOVASCULAR RISΚ ASSESMENT

CompletedOBSERVATIONAL
Enrollment

4,700

Participants

Timeline

Start Date

February 1, 2018

Primary Completion Date

January 30, 2019

Study Completion Date

January 30, 2019

Conditions
DyslipidemiasHyperlipidemiasRisk Factor, CardiovascularQuality of Life
Interventions
OTHER

Rosuvastatin

Hyperlipidemic patients treated with rosuvastatin

Trial Locations (1)

Unknown

Agia Olga Hospital, Athens

Sponsors
All Listed Sponsors
lead

Elpen Pharmaceutical Co. Inc.

INDUSTRY